Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Vystar(R) Corporation And Alatech Healthcare, LLC Announce FDA 510(k) Clearance For Exam Gloves Made With Vytex(R) NRL
Vystar Corporation and Alatech Healthcare, LLC announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the first exam gloves manufactured with Vytex® Natural Rubber Latex (NRL). Alatech plans to introduce exam gloves made with Vytex NRL in the near future.
generic viagra online
Viruses Are Sneakier Than We Thought
Viruses are molecular marauders, plundering cells for the res they
News of the day
New Study Shows Similar Benefits, No Additional Risks For Seniors Who Have Gastric Bypass
Morbidly obese seniors, age 65 and over, who had laparoscopic gastric bypass surgery lost nearly 76 percent of their excess weight after two years and had low complication rates and short hospital stays comparable to younger surgical patients, according to a new study presented today at the 26th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).
Endocrinology

Boston Scientific Announces European Approval For Its Latitude(R) Patient Management System

Boston Scientific Corporation (NYSE: BSX) announced CE Mark for its LATITUDE® Patient Management system. The LATITUDE system remotely monitors patients with implantable cardiac devices, gathering information on both the device and a patient"s heart health status. The system can also detect clinical events between scheduled physician visits and send relevant data directly to a patient"s physician. It will be launched in Europe in a phased approach beginning this week. "The wireless LATITUDE system will enable me to more closely monitor my patients while helping manage hospital workflow," said Konstantin M. Heinroth, M.D., Department of Medicine, Martin Luther-University Halle-Wittenberg, Halle, Germany. "I hope to provide my patients added convenience and the peace of mind that comes from knowing both their device and heart health status can be monitored." "Boston Scientific has enrolled more than 130,000 patients on the LATITUDE system since its introduction in the U.S. in 2006, making it the most rapidly adopted remote cardiac device monitoring system in the industry[1]," said Fred Colen, President, Boston Scientific Cardiac Rhythm Management. "We expect continued success as we introduce the demonstrated benefits of our LATITUDE system to patients and physicians in Europe. Remote monitoring technology provides a significant opportunity to further improve patient care." The LATITUDE system provides physicians actionable information that enables them to see changes in their patient"s cardiac health sooner than regularly scheduled follow-up visits. LATITUDE is the only remote cardiac device monitoring system with an optional wireless weight scale and blood pressure monitor, both of which are recommended by the European Society of Cardiology for the management of Class I heart failure patients. The international version of the LATITUDE system is compatible with the Company"s wireless TELIGEN® implantable cardioverter defibrillator (ICD) and COGNIS® cardiac resynchronization therapy defibrillator (CRT-D), the world"s smallest and thinnest high-energy devices. The first enrollments of European patients onto the LATITUDE system were performed by Dr. J.H. Ruiter at Medisch Centrum Hospital, Alkmaar, Netherlands and Dr. Peter Mortensen, Skejby University Hospital, Aarhus, Denmark. [1] Data based on number of patients at three years post-launch. Data on file. Boston Scientific


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009